ProText Mobility, Inc. Stock Price - TXTM

Best deals to access real time data!
SMALL CAP BASIC
Monthly Subscription
for only
$29.03
SMALL CAP PRO
Monthly Subscription
for only
$43.59
Real-Time Alerts for Volume Breakouts, Highs and Lows for OTC Markets and OTCBB
Monthly Subscription
for only
$49.99
VAT not included
Company Name Stock Ticker Symbol Market Type ISIN Company Description
Protext Mobility, Inc. (PL) TXTM Other OTC Common Stock Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded DELAYED
  +0.00 +0.00% 0.0006 0.0006 0.0005 0.0006 0.0006 16:12:30
Bid Price Ask Price Spread Spread % News
0.0001 0.0012 0.0011 91.67% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
34 24,019,671 $ 0.0005 $ 13.16k 102.75M 0.0000 - 0.0056
Last Trade Time Type Quantity Stock Price Currency
15:56:25 3 $0.00 USD

Protext Mobility, Inc. (PL) Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 1.74M 2.89B $ -1.45M - -1.20 1.72B
Short Interest Short % of Out Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
163.6k 0.01% $ - 0.00% - -

more financials information »

Protext Mobility, Inc. (PL) News

Historical TXTM Price Data

Period † Open High Low VWAP Min Vol Max Vol Avg. Daily Vol [m] Change %
1 Week0.00070.00080.00050.00007M29M19M-0.0001-14.29%
1 Month0.00150.00150.00050.00007M156M56M-0.0009-60.00%
3 Months0.00220.00340.00050.00007M553M92M-0.0016-72.73%
6 Months0.00010.00560.00010.00000598M123M0.0005500.00%
1 Year0.00010.00560.0000010.00000598M83M0.0005500.00%
3 Years0.00720.0130.0000010.00000598M26M-0.0066-91.67%
5 Years0.02220.300.0000010.00000598M20M-0.0216-97.30%

Protext Mobility, Inc. (PL) Description

Protext Mobility, operates two wholly owned subsidiaries; Plandai Biotechnology South Africa (PTY) LTD. and Cannabis Biosciences, Inc. The Company is engaged in the research and clinical testing of bioceutical products, all natural ingredients formulated for pharmaceutical applications and processed under pharma-grade conditions. Plandai Biotechnology SA, has the exclusive worldwide license to develop pharmaceutical applications and products using the Phytofare catechin complex, which was developed by Planda Biotechnology, Inc. Phytofare is a highly bioavailable extract produced from live green tea leaves. Our initial product, Phytofare Catechin Complex, has been clinically shown to have 10 times greater bioavailability over generic catechin extracts. Cannabis Biosciences is actively pursuing government licenses and permits that will allow it to use its proprietary processing and extraction technology to commence investigations and produce a full-profile cannabis extract, one that contains both CBD and the precursor acid form of THC (THC-A and THC-B) found in live cannabis plant. The Company's investigations will be designed to show that the Cannabis Biosciences extraction process, which will use live leaf and low temperatures to extract the phyto-chemicals, should leave the acid forms of THC intact, resulting in a non-psychoactive extract with full medicinal potential and having the heightened bioavailability of other Phytofare extracts.


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.